Skip to content

Clinical trials

Observational Diabetes Mellitus, Type 2 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Observational Country / region: Canada Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20071
20085
20091
20101
20111
20126
20133
20147
20154
20167
20177
20186
20191
20206
20211
20226
20235
20241
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Unknown status15
Recruiting9
Active, not recruiting5
Not yet recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S8
LMC Diabetes & Endocrinology Ltd.7
Canadian Network for Observational Drug Effect Studies, CNODES6
University of Toronto6
Mount Sinai Hospital, Canada5
University of Manitoba5
Bayer3
Canadian Medical and Surgical Knowledge Translation Research Group3
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
Unity Health Toronto3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 280
Diabetes Mellitus21
Obesity15
Diabetes Mellitus, Type 112
Cardiovascular Diseases10
Body Weight7
Diabetes, Gestational6
Hypertension5
Insulin Resistance5
Metabolic Syndrome4

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.